Combination drug for treating vascular disorder

Abstract

The present invention relates to a medicament for treating occlusive and/or ischemic vascular disorder comprising a carbostyril derivative and carnitine.

1 - 17 . (canceled) 
     
     
         18 . A method for treating cerebrovascular accident comprising administering to a patient in need thereof a therapeutically effective amount of a combination comprising as active ingredients
 6-[4-(1-cyclohexyl-1H-1-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril or a salt thereof, and carnitine or a salt thereof, in a ratio of 0.1 to 100 parts by weight of carnitine or a salt thereof per 1 part by weight of the carbostyril derivative or a salt thereof.   
     
     
         19 . The method of  claim 18  wherein the cerebrovascular accident is acute cerebral infarction, chronic cerebral infarction, transient ischemic attack, intracerebral hemorrhage, subarachnoid hemorrhage, subdural hematoma, cerebrocortical dysfunction, or cranial neuronal cell death. 
     
     
         20 . The method of  claim 18  wherein the carnitine is L-carnitine or levocarnitine chloride. 
     
     
         21 . The method of  claim 18  wherein the ratio is 1 to 20 parts by weight of carnitine or a salt thereof per 1 part by weight of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril or a salt thereof.